Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - TENGION INCex99-1.htm


Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 13, 2010

Tengion, Inc.
(Exact name of registrant as specified in its charter)

(Commission File Number)

(State or other jurisdiction of
(I.R.S. Employer Identification No.)

2900 Potshop Lane, Suite 100
East Norriton, PA 19403
(610) 292-8364
 (Address of principal executive offices, with zip code)

(610) 292-8364
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  [  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 7.01 Regulation FD Disclosure

On September 13, 2010 Tengion, Inc. (“Tengion”) will be providing a company update at the Rodman and Renshaw 12th Annual Healthcare Conference.  A copy of the presentation materials to be used at this conference and in other meetings with the investment community are attached hereto as Exhibit 99.1 and incorporated herein by reference.  These materials also are available on our website at

The information referenced in this Current Report on Form 8-K (including Exhibit 99.1 referenced in Item 9.01 below) is being “furnished” under “Item 7.01. Regulation FD Disclosure” and, as such, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed by Tengion pursuant to the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

   (b) Exhibits.



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  September 13, 2010
/s/ Joseph W. La Barge
Joseph W. La Barge
Executive Director, Corporate Counsel & Secretary



Exhibit Index